Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings Inc.
WKN: A3C4ZC / Symbol: XERS / Name: Xeris Biopharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
5,42 €
1,76 %
Xeris Biopharma (NASDAQ:XERS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for XERS provided by MarketBeat
Xeris Biopharma (XERS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for XERS provided by MarketBeat


Neueste Beiträge
Susquehanna in Canadian Pacific Railway diskutieren, Canadian Pacific City Kansas Ltd.